Collectively, our in vivo and in vitro results unequivocally demonstrated that inhibition of GHSR mitigates neuroinflammation under obesity, likely by reprogramming the AMPK-autophagy axis in neurons. Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.